Dr Mathias Kroll has over 27 years’ experience in biopharmaceutical research and business development. He joined Cynata Therapeutics Ltd. in April 2024 as Chief Business Officer. Dr. Kroll has extensive global experience in biopharmaceutical business transactions of all kinds and has created a large number of partnerships ranging in value up to several billion dollars.